CLDF Title
Home | Contact Us | Bookmark
Centers of Educational Expertise  
Live CME Events Webcasts Slide Library Abstract Library CLDF 2019 Year in Review Conference Highlights
Reuters Health Information (2014-03-20): Geron says FDA halts patient enrollment in another cancer trial

Drug & Device Development

Geron says FDA halts patient enrollment in another cancer trial

Last Updated: 2014-03-20 11:21:47 -0400 (Reuters Health)

(Reuters) - Geron Corp said the U.S. Food and Drug Administration ordered a halt to new patient enrollments in an early-stage trial of its blood cancer drug, imetelstat, over concerns about liver damage.

The halt announced on Thursday was for enrollments in a trial sponsored by the Mayo Clinic, and comes a week after the FDA ordered Geron to cease company-sponsored trials of the drug over similar concerns.

Imetelstat is Geron's only remaining drug and was touted as the company's savior after curing 22% of myelofibrosis patients in a trial last year.

Geron said on Thursday that it could not enroll new patients in the Mayo Clinic-sponsored study, but that the trial could continue with patients benefiting from the drug.

The FDA on March 12 had ordered a complete halt to trials that were testing imetelstat to treat thrombocythemia and multiple myeloma, two forms of blood cancer.

The Mayo Clinic had ceased enrollments in January and said that about 20 of 79 patients enrolled had dropped out.

Geron stock lost 62% of its value on March 12 when the FDA halted the company trials. Since then the stock has risen 35% and closed at $2.28 on Wednesday on the Nasdaq.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2021 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.